Medicines Co Quick Ratio (MDCO) starting from the third quarter 2019 to third quarter 2018, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Medicines Co  (NASDAQ: MDCO)

Medicines Co's Quick Ratio

MDCO's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2019, Quick Ratio fell to 0.63 a new company low.

Within Major Pharmaceutical Preparations industry 421 other companies have achieved higher Quick Ratio than Medicines Co in third quarter 2019. While Quick Ratio total ranking in the third quarter 2019 has deteriorated compared to the prior quarter from 567 to 2317.

Explain Quick Ratio?
How much Cash & cash equivalents MDCO´s has?
What are MDCO´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MDCO Quick Ratio (Sep 30 2019)
Q3		 (Jun 30 2019)
Q2		 (Mar 31 2019)
Q1		 (Dec 31 2018)
Q4		 (Sep 30 2018)
Q3
Y / Y Current Liabilities Change 444.18 % -24.23 % -42.83 % -66.72 % -39.68 %
Y / Y Cash & cash equivalent Change 103.63 % 76.35 % -15.98 % 59.14 % -36.91 %
Quick Ratio MRQ 0.63 5.06 3.2 4.12 1.69
MDCO's Total Ranking # 2317 # 567 # 869 # 301 # 1320
Seq. Current Liabilities Change 561.53 % 1.3 % 8.1 % -24.88 % -7.89 %
Seq. Cash & cash equivalent Change -17.09 % 60.17 % -16.12 % 82.81 % -28.19 %



Quick Ratio third quarter 2019 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 422
Healthcare Sector # 731
Overall Market # 2317


Quick Ratio Statistics
High Average Low
5.06 2.33 0.63
(Jun 30 2019)   (Sep 30 2019)




Financial Statements
Medicines Co's Current Liabilities $ 423 Millions Visit MDCO's Balance sheet
Medicines Co's Cash & cash equivalent $ 268 Millions Visit MDCO's Balance sheet
Source of MDCO's Sales Visit MDCO's Sales by Geography


Cumulative Medicines Co's Quick Ratio

MDCO's Quick Ratio for the trailling 12 Months

MDCO Quick Ratio

 (Sep 30 2019)
12 Months		 (Jun 30 2019)
12 Months		 (Mar 31 2019)
12 Months		 (Dec 31 2018)
12 Months		 (Sep 30 2018)
12 Months
Y / Y Current Liabilities TTM Growth 35.83 % -47.27 % -69.5 % -75.42 % -68.35 %
Y / Y Cash & cash equivalent TTM Growth 46.35 % 14.55 % -18.87 % -29.55 % -53.51 %
Quick Ratio TTM 1.7 3.41 2.67 2.41 1.58
Total Ranking TTM # 4600 # 4396 # 526 # 400 # 1089
Seq. Current Liabilities TTM Growth 131.19 % -7.21 % -14.29 % -26.13 % -10.25 %
Seq. Cash & cash equivalent TTM Growth 15.2 % 18.48 % -4.82 % 12.66 % -9.83 %

Quick ratio ranking by company, industry and sector >> Back to MDCO Financial Strength Comparisons >> Go to Compare MDCO Quick Ratio to its Competitors

On the trailing twelve months basis Due to in Current Liabilities in the Q3 2019 to $423.14 millions, cumulative Quick Ratio decreased to 1.7 below the Medicines Co average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 462 other companies have achieved higher Quick Ratio than Medicines Co. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2019 from 4396 to 4600.

Explain Quick Ratio?
How much Cash & cash equivalents MDCO´s has?
What are MDCO´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 463
Healthcare Sector # 899
Within the Market # 4600


trailing twelve months Quick Ratio Statistics
High Average Low
3.41 1.74 0.84
(Jun 30 2019)   (Dec 31 2017)




Companies with similar Quick Ratio in the quarter ending Sep 30 2019, within Major Pharmaceutical Preparations Industry Quick RatioSep 30 2019 MRQ Cash & cash equivalentSep 30 2019 MRQ Current Liabilities
Zoetis Inc   1.74 $ 1,827.000  Millions$ 1,052.000  Millions
Hutchmed china Limited  1.73 $ 201.575  Millions$ 116.290  Millions
Citius Pharmaceuticals Inc   1.73 $ 7.951  Millions$ 4.608  Millions
Summit Therapeutics Inc   1.69 $ 17.600  Millions$ 10.394  Millions
Cti Biopharma Corp   1.67 $ 46.732  Millions$ 27.919  Millions
Checkpoint Therapeutics inc   1.67 $ 13.060  Millions$ 7.811  Millions
Sophiris Bio Inc.  1.64 $ 6.301  Millions$ 3.841  Millions
Regeneron Pharmaceuticals Inc   1.63 $ 2,877.900  Millions$ 1,765.400  Millions
Proteo Inc  1.62 $ 0.132  Millions$ 0.081  Millions
Alkermes Plc   1.59 $ 587.182  Millions$ 370.394  Millions
Aclaris Therapeutics Inc   1.58 $ 61.530  Millions$ 38.989  Millions
Zomedica Corp   1.58 $ 2.488  Millions$ 1.578  Millions
Wave Life Sciences Ltd   1.57 $ 209.009  Millions$ 133.411  Millions
Contrafect Corporation  1.49 $ 10.502  Millions$ 7.031  Millions
Biomarin Pharmaceutical Inc  1.46 $ 720.792  Millions$ 493.745  Millions
Stablecoin Development Corporation  1.44 $ 9.020  Millions$ 6.252  Millions
Akari Therapeutics Plc  1.44 $ 6.269  Millions$ 4.350  Millions
Durect Corp  1.40 $ 56.961  Millions$ 40.693  Millions
Intec Pharma Ltd   1.40 $ 15.766  Millions$ 11.299  Millions
Cumberland Pharmaceuticals Inc   1.39 $ 29.244  Millions$ 21.053  Millions
Moleculin Biotech Inc   1.39 $ 15.409  Millions$ 11.119  Millions
One World Products Inc   1.38 $ 1.017  Millions$ 0.739  Millions
Bellicum Pharmaceuticals Inc   1.35 $ 103.303  Millions$ 76.438  Millions
Forte Biosciences Inc   1.33 $ 55.342  Millions$ 41.746  Millions
Kamada Ltd   1.30 $ 42.662  Millions$ 32.739  Millions
Serina Therapeutics Inc   1.30 $ 3.768  Millions$ 2.907  Millions
Puma Biotechnology Inc   1.29 $ 110.439  Millions$ 85.827  Millions
Sio Gene Therapies Inc   1.28 $ 60.300  Millions$ 47.279  Millions
Cypherpunk Technologies Inc   1.27 $ 10.058  Millions$ 7.931  Millions
Vaccinex Inc   1.24 $ 8.578  Millions$ 6.896  Millions

Date modified: 2026-09-08T15:09:42+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.